Posted by Michael Wonder on 02 Dec 2017
Amazon is in exploratory talks with generic drug makers
30 November 2017 - Amazon has talked to makers of generic drugs, including Mylan and Sandoz, about a potential entry into the pharmacy space.
Amazon has held preliminary talks with makers of generic drugs about its potential entry into the pharmacy space, according to people familiar with the discussions.
The conversations, including with generics giants Mylan and Sandoz, a unit of Novartis, have been high-level, and the nature of Amazon's plans isn't yet clear, said the people, who asked not to be named because the discussions aren't public.
One of the people said the conversations are about Amazon taking a role in drug purchasing, potentially disrupting a space now dominated by distributors McKesson, AmerisourceBergen and Cardinal Health. Generics manufacturers are eager to establish a relationship with Amazon as part of 2018 business plans, the person said.
